TCF7 has been reported to be co-expressed with NBR2, and NBR2 deficiency leads to decreased TCF7 expression in hepatoblastoma cells, along with the down-regulation of the TCF7 protein that is involved in cell cycle progression, glucose entrapment, and epithelial-mesenchymal transition (EMT). The gene discussed is NBR2; the disease is hepatoblastoma.